ICL Israel Chemicals Ltd ICL
Stock research in plain language · As of Oct 12, 2026 · updated once a week, after the trading week closes

Daily candles, 50 and 200-day averages and volume · updated every trading day · click to open the live chart
What the company does
ICL Israel Chemicals Ltd is a mid-cap company in the Basic Materials sector (Agricultural Inputs), with a market value of $6.5B, based in the USA.
It employs about 12,000 people and has been listed since Sep 24, 2014.
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products.
Cheap or expensive? no comparison basis
Price-to-earnings (p/e): 20.9. We have no good comparison group for this stock, so the number stands alone.
Revenue is growing 16% versus the same quarter last year.
On analysts' next-year forecasts the multiple rises to 55.6 — they expect lower earnings.
The average analyst price target is 5.81, 16% above the current price (their view, not ours).
The stock sits at 18% of its one-year range (0% = the low, 100% = the high).
The risks
- No risk flags were detected from the data we have.
Strengths
- ✅ Profitable — 6 of every 100 dollars of revenue stays as profit.
- ✅ Generates free cash flow — profit becomes cash in the bank.
- ✅ Revenue is growing 16% a year.
- ✅ Pays a dividend (4.1% a year).
What changed this week
Over the past week the stock fell 0.4% (for comparison: S&P 500 +1.2%, sector ETF XLB +1.2%).
No notable news about the company was found in the past week.
What changed since last week
This is the first summary for this stock; from next week this section shows what changed.
A description of facts from the filings and the market — not investment advice or a recommendation. "Cheap" and "expensive" are always relative to the comparison group.